James Cummings

2022

In 2022, James Cummings earned a total compensation of $1.9M as Chief Medical Officer at Biota Pharmaceuticals, a 19% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$86,000
Option Awards$1,184,479
Salary$430,000
Stock Awards$222,688
Other$10,956
Total$1,934,123

Cummings received $1.2M in option awards, accounting for 61% of the total pay in 2022.

Cummings also received $86K in non-equity incentive plan, $430K in salary, $222.7K in stock awards and $11K in other compensation.

Rankings

In 2022, James Cummings' compensation ranked 1,811th out of 5,756 executives tracked by ExecPay. In other words, Cummings earned more than 68.5% of executives.

ClassificationRankingPercentile
All
1,811
out of 5,756
69th
Division
Manufacturing
948
out of 3,133
70th
Major group
Chemicals And Allied Products
384
out of 1,419
73rd
Industry group
Drugs
351
out of 1,320
73rd
Industry
Biological Products, Except Diagnostic Substances
87
out of 291
70th

Pay ratio

James Cummings' Pay$1,934,123
Median Employee's Pay$163,906
Pay Ratio

12

to 1

In 2022, the annual total compensation of James Cummings was $1,934,123.

The annual total compensation of the median employee at Biota Pharmaceuticals was $163,906.

The ratio of James Cummings' pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on April 28, 2023.

Cummings' colleagues

We found two more compensation records of executives who worked with James Cummings at Biota Pharmaceuticals in 2022.

2022

Andrei Floroiu

Biota Pharmaceuticals

Chief Executive Officer

2022

Sean Tucker

Biota Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like